Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalle Andreasson

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Lakartidningen|October 4, 2017
[Gastric bypass versus sleeve, pros and cons]Kalle Andreasson, Per Videhult
International Journal of Colorectal Disease|October 18, 2017
Low risk of complications in patients with first-time acute uncomplicated diverticulitisAbbas Chabok, Kalle Andreasson, Maziar Nikberg
Expert Opinion on Biological Therapy|August 2, 2007
Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancerTorbjörn Ramqvist, Kalle Andreasson, Tina Dalianis
Plos One|July 27, 2010
CD4+ and CD8+ T cells can act separately in tumour rejection after immunization with murine pneumotropic virus chimeric Her2/neu virus-like particlesKalle Andreasson, Mathilda Eriksson, Karin Tegerstedt, et al.
Lakartidningen|October 7, 2006
[Virus-like particles as cancer vaccine. Great expectations--not only for papillomavirus associated cancer]Karin Tegerstedt, Kalle Andreasson, Hanna Dahlstrand, et al.
Scandinavian Journal of Gastroenterology|November 6, 2014
No antibiotics in acute uncomplicated diverticulitis: does it work?Daniel Isacson, Kalle Andreasson, Maziar Nikberg, et al.
Seminars in Cancer Biology|May 7, 2009
KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus researchTina Dalianis, Torbjörn Ramqvist, Kalle Andreasson, et al.
Upsala Journal of Medical Sciences|May 27, 2014
The choice of anaesthetic--sevoflurane or propofol--and outcome from cancer surgery: a retrospective analysisMats Enlund, Anders Berglund, Kalle Andreasson, et al.
Plos One|August 23, 2011
Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumorMathilda Eriksson, Kalle Andreasson, Joachim Weidmann, et al.
Anticancer Research|August 6, 2005
Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancerKarin Tegerstedt, Andrea Vlastos Franzén, Kalle Andreasson, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Lakartidningen|October 4, 2017
[Gastric bypass versus sleeve, pros and cons]Kalle Andreasson, Per Videhult
International Journal of Colorectal Disease|October 18, 2017
Low risk of complications in patients with first-time acute uncomplicated diverticulitisAbbas Chabok, Kalle Andreasson, Maziar Nikberg
Expert Opinion on Biological Therapy|August 2, 2007
Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancerTorbjörn Ramqvist, Kalle Andreasson, Tina Dalianis
Plos One|July 27, 2010
CD4+ and CD8+ T cells can act separately in tumour rejection after immunization with murine pneumotropic virus chimeric Her2/neu virus-like particlesKalle Andreasson, Mathilda Eriksson, Karin Tegerstedt, et al.
Lakartidningen|October 7, 2006
[Virus-like particles as cancer vaccine. Great expectations--not only for papillomavirus associated cancer]Karin Tegerstedt, Kalle Andreasson, Hanna Dahlstrand, et al.
Scandinavian Journal of Gastroenterology|November 6, 2014
No antibiotics in acute uncomplicated diverticulitis: does it work?Daniel Isacson, Kalle Andreasson, Maziar Nikberg, et al.
Seminars in Cancer Biology|May 7, 2009
KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus researchTina Dalianis, Torbjörn Ramqvist, Kalle Andreasson, et al.
Upsala Journal of Medical Sciences|May 27, 2014
The choice of anaesthetic--sevoflurane or propofol--and outcome from cancer surgery: a retrospective analysisMats Enlund, Anders Berglund, Kalle Andreasson, et al.
Plos One|August 23, 2011
Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumorMathilda Eriksson, Kalle Andreasson, Joachim Weidmann, et al.
Anticancer Research|August 6, 2005
Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancerKarin Tegerstedt, Andrea Vlastos Franzén, Kalle Andreasson, et al.
Pageof 2